FDANonrulemakingFDA-2020-D-1530
Who commented on this docket
Control of Nitrosamine Impurities in Human Drugs; Guidance for Industry; Availability
2 organizations filed 5 public comments on Control of Nitrosamine Impurities in Human Drugs; Guidance for Industry; Availability, at the Food and Drug Administration.
Organizations
2
Comments
5
RIN
—
Comment window
—
Commenters (2)
- Association for Accessible Medicinestrade assoc.3 filings · confidence 97%
- Consumer Healthcare Products Associationtrade assoc.2 filings · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.